Mengqi Liao, Ling Men, Ming Gong, Yuanyuan Li, Yan Wang, Desheng Xu, Jienan Luan, Hua Zhou, Mengnan Liu, Mingtai Chen
{"title":"线粒体自噬:中药缓解心肌缺血/再灌注损伤的新途径。","authors":"Mengqi Liao, Ling Men, Ming Gong, Yuanyuan Li, Yan Wang, Desheng Xu, Jienan Luan, Hua Zhou, Mengnan Liu, Mingtai Chen","doi":"10.1007/s10495-025-02178-x","DOIUrl":null,"url":null,"abstract":"<p><p>Myocardial ischemia-reperfusion injury (MIRI) has a high incidence and is difficult to cure. Studies have shown that mitophagy is the key mechanism. This review systematically summarizes all documented herbal preparations and bioactive monomers targeting mitophagy for MIRI treatment, which may serve as a valuable reference for future research on herbal medicine-mediated mitophagy regulation. We conducted comprehensive literature searches in PubMed, Embase, Web of Science, and CNKI databases using the keywords \"cardiovascular diseases,\" \"mitophagy,\" \"myocardial ischemia-reperfusion injury,\" \"herbal medicine,\" \"mechanism,\" and \"therapeutic\" for studies published within the last five years up to July 2025. Studies on herbal medicine interventions unrelated to mitophagy were excluded. Our analysis reveals that mitophagy plays a crucial role in attenuating the detrimental effects of MIRI. Furthermore, herbal medicine demonstrates therapeutic efficacy in maintaining homeostatic balance of mitophagy during MIRI. Herbal medicines can precisely regulate mitophagy via the PTEN-induced putative kinase 1 (PINK1)-parkin pathway, and modulate the expression of BCL2 interacting protein 3 (BNIP3), FUN14 domain-containing protein 1 (FUNDC1), NIP3-like protein X (NIX). Herbal medicines exert protective effects against MIRI through diverse mechanisms and signaling pathways by targeting mitophagy. While mitophagy represents a promising frontier for future cardiovascular research, current herbal medicine applications remain predominantly confined to animal and cellular models, with only limited clinical translation. The findings presented herein are anticipated to provide clinicians and cardiovascular researchers with valuable therapeutic strategies and novel research directions.</p>","PeriodicalId":8062,"journal":{"name":"Apoptosis","volume":" ","pages":""},"PeriodicalIF":8.1000,"publicationDate":"2025-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Mitophagy: a novel avenue for herbal medicines alleviating myocardial ischemia/reperfusion injury.\",\"authors\":\"Mengqi Liao, Ling Men, Ming Gong, Yuanyuan Li, Yan Wang, Desheng Xu, Jienan Luan, Hua Zhou, Mengnan Liu, Mingtai Chen\",\"doi\":\"10.1007/s10495-025-02178-x\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Myocardial ischemia-reperfusion injury (MIRI) has a high incidence and is difficult to cure. Studies have shown that mitophagy is the key mechanism. This review systematically summarizes all documented herbal preparations and bioactive monomers targeting mitophagy for MIRI treatment, which may serve as a valuable reference for future research on herbal medicine-mediated mitophagy regulation. We conducted comprehensive literature searches in PubMed, Embase, Web of Science, and CNKI databases using the keywords \\\"cardiovascular diseases,\\\" \\\"mitophagy,\\\" \\\"myocardial ischemia-reperfusion injury,\\\" \\\"herbal medicine,\\\" \\\"mechanism,\\\" and \\\"therapeutic\\\" for studies published within the last five years up to July 2025. Studies on herbal medicine interventions unrelated to mitophagy were excluded. Our analysis reveals that mitophagy plays a crucial role in attenuating the detrimental effects of MIRI. Furthermore, herbal medicine demonstrates therapeutic efficacy in maintaining homeostatic balance of mitophagy during MIRI. Herbal medicines can precisely regulate mitophagy via the PTEN-induced putative kinase 1 (PINK1)-parkin pathway, and modulate the expression of BCL2 interacting protein 3 (BNIP3), FUN14 domain-containing protein 1 (FUNDC1), NIP3-like protein X (NIX). Herbal medicines exert protective effects against MIRI through diverse mechanisms and signaling pathways by targeting mitophagy. While mitophagy represents a promising frontier for future cardiovascular research, current herbal medicine applications remain predominantly confined to animal and cellular models, with only limited clinical translation. The findings presented herein are anticipated to provide clinicians and cardiovascular researchers with valuable therapeutic strategies and novel research directions.</p>\",\"PeriodicalId\":8062,\"journal\":{\"name\":\"Apoptosis\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":8.1000,\"publicationDate\":\"2025-09-12\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Apoptosis\",\"FirstCategoryId\":\"99\",\"ListUrlMain\":\"https://doi.org/10.1007/s10495-025-02178-x\",\"RegionNum\":2,\"RegionCategory\":\"生物学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"BIOCHEMISTRY & MOLECULAR BIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Apoptosis","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1007/s10495-025-02178-x","RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
心肌缺血再灌注损伤(MIRI)发病率高,治疗难度大。研究表明,线粒体自噬是关键机制。本文系统总结了已有文献记载的靶向线粒体自噬治疗MIRI的草药制剂和生物活性单体,为今后草药介导的线粒体自噬调控研究提供有价值的参考。我们对PubMed、Embase、Web of Science和CNKI数据库进行了全面的文献检索,检索关键词为“心血管疾病”、“线粒体自噬”、“心肌缺血-再灌注损伤”、“草药”、“机制”和“治疗”,检索了截至2025年7月的近5年内发表的研究。排除了与线粒体自噬无关的草药干预研究。我们的分析表明,线粒体自噬在减轻MIRI的有害影响中起着至关重要的作用。此外,草药在维持MIRI期间线粒体自噬的稳态平衡方面显示出治疗效果。草药可以通过pten诱导的推测激酶1 (PINK1)-parkin通路精确调节线粒体自噬,调节BCL2相互作用蛋白3 (BNIP3)、含FUN14结构域蛋白1 (FUNDC1)、nip3样蛋白X (NIX)的表达。草药通过多种机制和信号通路,以线粒体自噬为靶点,发挥对MIRI的保护作用。虽然线粒体自噬是未来心血管研究的一个有前途的前沿,但目前的草药应用仍然主要局限于动物和细胞模型,只有有限的临床转化。本文的研究结果有望为临床医生和心血管研究者提供有价值的治疗策略和新的研究方向。
Mitophagy: a novel avenue for herbal medicines alleviating myocardial ischemia/reperfusion injury.
Myocardial ischemia-reperfusion injury (MIRI) has a high incidence and is difficult to cure. Studies have shown that mitophagy is the key mechanism. This review systematically summarizes all documented herbal preparations and bioactive monomers targeting mitophagy for MIRI treatment, which may serve as a valuable reference for future research on herbal medicine-mediated mitophagy regulation. We conducted comprehensive literature searches in PubMed, Embase, Web of Science, and CNKI databases using the keywords "cardiovascular diseases," "mitophagy," "myocardial ischemia-reperfusion injury," "herbal medicine," "mechanism," and "therapeutic" for studies published within the last five years up to July 2025. Studies on herbal medicine interventions unrelated to mitophagy were excluded. Our analysis reveals that mitophagy plays a crucial role in attenuating the detrimental effects of MIRI. Furthermore, herbal medicine demonstrates therapeutic efficacy in maintaining homeostatic balance of mitophagy during MIRI. Herbal medicines can precisely regulate mitophagy via the PTEN-induced putative kinase 1 (PINK1)-parkin pathway, and modulate the expression of BCL2 interacting protein 3 (BNIP3), FUN14 domain-containing protein 1 (FUNDC1), NIP3-like protein X (NIX). Herbal medicines exert protective effects against MIRI through diverse mechanisms and signaling pathways by targeting mitophagy. While mitophagy represents a promising frontier for future cardiovascular research, current herbal medicine applications remain predominantly confined to animal and cellular models, with only limited clinical translation. The findings presented herein are anticipated to provide clinicians and cardiovascular researchers with valuable therapeutic strategies and novel research directions.
期刊介绍:
Apoptosis, a monthly international peer-reviewed journal, focuses on the rapid publication of innovative investigations into programmed cell death. The journal aims to stimulate research on the mechanisms and role of apoptosis in various human diseases, such as cancer, autoimmune disease, viral infection, AIDS, cardiovascular disease, neurodegenerative disorders, osteoporosis, and aging. The Editor-In-Chief acknowledges the importance of advancing clinical therapies for apoptosis-related diseases. Apoptosis considers Original Articles, Reviews, Short Communications, Letters to the Editor, and Book Reviews for publication.